Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 985 - 992 of 11616 results
MintzTech Connect: All Things Technology — September 2023
September 12, 2023| Article| Viewpoint
Mental Health Startups Face A Buyer’s Market
September 12, 2023| News
Expanding Existing Bereavement Leave Policies to Account for Fertility Related Losses
September 11, 2023| Blog| Viewpoint
Changes May be Coming to White-Collar Exemption Salary Thresholds
September 11, 2023| Blog| Viewpoint
Big Pharma’s Fight Over Medicare Drug Price Negotiations Faces Multiple Challenges
September 11, 2023| News
Harvard Law Grads Give Boston Cold Shoulder, Take Jobs Elsewhere
September 11, 2023| News
Data Center Pay To Stay?
September 11, 2023| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.